{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:32:02Z","timestamp":1762101122845},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 39970316, 30470638 and 81070483"],"award-info":[{"award-number":["Nos. 39970316, 30470638 and 81070483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.leukres.2010.11.012","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T09:34:17Z","timestamp":1292492057000},"page":"1074-1079","source":"Crossref","is-referenced-by-count":4,"title":["A small molecule significantly inhibits the bcr\/abl fusion gene at the mRNA level in human chronic myelogenous leukemia"],"prefix":"10.1016","volume":"35","author":[{"given":"Qun","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanying","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.11.012_bib0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2010.11.012_bib0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myeloid leukemia","volume":"300","author":"De Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2010.11.012_bib0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210 bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.leukres.2010.11.012_bib0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2010.11.012_bib0025","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.leukres.2010.11.012_bib0030","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.leukres.2010.11.012_bib0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(02)07679-1","article-title":"BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study","volume":"359","author":"von Bubnoff","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2010.11.012_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","article-title":"Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia","volume":"16","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.leukres.2010.11.012_bib0045","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1586\/14737140.8.9.1387","article-title":"Abl tyrosine kinase inhibitors for overriding Bcr-Abl\/T315I: from the second to third generation","volume":"8","author":"Tanaka","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.leukres.2010.11.012_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2006.00282.x","article-title":"Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials","volume":"27","author":"Thomas","year":"2006","journal-title":"Acta Pharmacol Sinica"},{"key":"10.1016\/j.leukres.2010.11.012_bib0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2010.11.012_bib0060","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1182\/blood.V66.6.1384.1384","article-title":"Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome","volume":"66","author":"Ogura","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.11.012_bib0065","first-page":"337","article-title":"Establishment of an imatinib resistant cell line K562\/G01 and its characterization","volume":"25","author":"Qi","year":"2004","journal-title":"Chin J Hematol"},{"key":"10.1016\/j.leukres.2010.11.012_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/10245330701384179","article-title":"Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells","volume":"12","author":"Baran","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2010.11.012_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0145-2126(98)00160-X","article-title":"A novel aminosteroid is active for proliferation inhibition and differentiation induction of human acute myeloid leukemia HL-60 cells","volume":"23","author":"He","year":"1999","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.11.012_bib0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0145-2126(00)00153-3","article-title":"The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cell in vitro and in vivo","volume":"25","author":"He","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.11.012_bib0085","first-page":"91","article-title":"A new 2-aminosteroid induces cellular differentiation and upregulates the expression of MafB and Egr-1 genes respectively in HL-60 and K562 leukemia cells","volume":"118","author":"He","year":"2005","journal-title":"Chin Med J"},{"key":"10.1016\/j.leukres.2010.11.012_bib0090","unstructured":"He Q, Dong J, Zhen HY, Zhang J. Chinese Patent. CN101456890 (2009)."},{"key":"10.1016\/j.leukres.2010.11.012_bib0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/107327480901600203","article-title":"Tailoring tyrosine kinase inhibitor therapy in chronic myeloid leukemia","volume":"16","author":"Mauro","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.leukres.2010.11.012_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/187152909787581363","article-title":"Resistance to imatinib in chronic myeloid leukemia and therapeutic approaches to circumvent the problem","volume":"9","author":"Breccia","year":"2009","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.leukres.2010.11.012_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11523-008-0100-y","article-title":"Treatment selection after imatinib resistance in chronic myeloid leukemia","volume":"4","author":"Jabbour","year":"2009","journal-title":"Target Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610005576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610005576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T18:54:35Z","timestamp":1592160875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610005576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0145212610005576"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.11.012","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}